E-LIB Suche - Ergebnisse für: Gish R. G

1

Bulevirtide improves health-related quality of life measure..:

Buti, M. ; Wedemeyer, H. ; Aleman, S....
Digestive and Liver Disease. 55 (2023) - p. S72-S73 , 2023

Link: https://doi.org/10.1016/..

2

While hepatocellular carcinoma (HCC) has become the leading..:

Wang, J. ; Gish, R.G. ; Liu, B...
Journal of Hepatology. 68 (2018) - p. S416 , 2018

Link: https://doi.org/10.1016/..

3

RNA interference therapy with ARC-520 Injection results in ..:

Yuen, M.-F. ; Liu, K. ; Given, B....
Journal of Hepatology. 68 (2018) - p. S526 , 2018

Link: https://doi.org/10.1016/..

4

Hepatitis B surface antigen loss and sustained viral suppre..:

Wong, R. J. ; Nguyen, M. T. ; Trinh, H. N....
Journal of Viral Hepatitis. 24 (2017) 12 - p. 1089-1097 , 2017

Link: https://doi.org/10.1111/..

5

Prolonged RNA interference therapy with ARC-520 Injection i..:

Yuen, M.-F. ; Liu, K. ; Chan, H.L....
Journal of Hepatology. 66 (2017) 1 - p. S27 , 2017

Link: https://doi.org/10.1016/..

6

Differential Reductions in Viral Antigens Expressed from CC..:

Yuen, M.-F. ; Chan, H.L.Y. ; Liu, K....
Journal of Hepatology. 64 (2016) 2 - p. S390-S391 , 2016

Link: https://doi.org/10.1016/..

7

Predicting HBsAg Clearance Responses during ARC-520 RNA Int..:

Walsh, R. ; Hammond, R. ; Yuen, L....
Journal of Hepatology. 64 (2016) 2 - p. S602 , 2016

Link: https://doi.org/10.1016/..

8

Community‐based real‐world treatment outcomes of sofosbuvir..:

Wong, R. J. ; Nguyen, M. T. ; Trinh, H. N....
Journal of Viral Hepatitis. 24 (2016) 1 - p. 17-21 , 2016

Link: https://doi.org/10.1111/..

9

A simple and inexpensive point‐of‐care test for hepatitis B..:

Gish, R. G. ; Gutierrez, J. A. ; Navarro‐Cazarez, N....
Journal of Viral Hepatitis. 21 (2014) 12 - p. 905-908 , 2014

Link: https://doi.org/10.1111/..

10

759 IMPACT OF ENTECAVIR VERSUS LAMIVUDINE ON HEPATIC COVALE..:

Bowden, S. ; Locarnini, S. ; Chang, T.-T....
Journal of Hepatology. 58 (2013) - p. S308-S309 , 2013

Link: https://doi.org/10.1016/..

11

Hepatitis B in the Greater San Francisco Bay Area: an integ..:

Gish, R.G. ; Cooper, S.L.
Journal of Viral Hepatitis. 18 (2010) 4 - p. , 2010

Link: https://doi.org/10.1111/..

12

Loss of HBsAg antigen during treatment with entecavir or la..:

Gish, R. G. ; Chang, T.-T. ; Lai, C.-L....
Journal of Viral Hepatitis. 17 (2010) 1 - p. 16-22 , 2010

Link: https://doi.org/10.1111/..

13

Is chronic hepatitis B being undertreated in the United Sta..:

Cohen, C. ; Holmberg, S. D. ; McMahon, B. J....
Journal of Viral Hepatitis. 18 (2010) 6 - p. 377-383 , 2010

Link: https://doi.org/10.1111/..

14

Results of up to 2 years of entecavirvslamivudine therapy i..:

Chang, T.-T. ; Chao, Y.-C. ; Gorbakov, V. V....
Journal of Viral Hepatitis. 16 (2009) 11 - p. 784-789 , 2009

Link: https://doi.org/10.1111/..

15

Evaluating anti‐viral drug selection and treatment duration..:

VEENSTRA, D. L. ; SPACKMAN, D. E. ; BISCEGLIE, A...
Alimentary Pharmacology & Therapeutics. 27 (2008) 12 - p. 1240-1252 , 2008

Link: https://doi.org/10.1111/..